Thomas DesRosier, See Remarks at Seres Therapeutics, Inc. (MCRB), sold 79 shares at $7.53 ($595) on 2026-05-18, disclosed to the SEC on 2026-05-19.
Scheduled sale ($595) by See Remarks under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| MCRB | SELL | 2025-11-18 | $1K | — | Filing → |
| MCRB | SELL | 2025-08-19 | $1K | — | Filing → |
| MCRB | SELL | 2025-05-19 | $575 | — | Filing → |